Cargando…
Current Status of New Anticoagulants in the Management of Venous Thromboembolism
Venous Thromboembolism, manifested as deep venous thrombosis and pulmonary embolism, is a common problem associated with significant morbidity, mortality, and resource expenditure. Unfractionated heparin, low-molecular-weight heparin, and vitamin K antagonists are the most common treatment and proph...
Autores principales: | Montoya, Roberto C., Gajra, Ajeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310205/ https://www.ncbi.nlm.nih.gov/pubmed/22496694 http://dx.doi.org/10.1155/2012/856341 |
Ejemplares similares
-
Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions
por: Nakamura, Mashio, et al.
Publicado: (2017) -
New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010) -
New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016) -
New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: McRae, Simon J, et al.
Publicado: (2005) -
New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: Kim, Joo Hee, et al.
Publicado: (2017)